Liquid Biopsies for Cancer Genotyping: Coming of Age?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 36757332.
- Also identified by DOI 10.1158/1078-0432.CCR-22-3087.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Precision oncology is predicated on optimal molecular profiling that is "fit for purpose" to identify therapeutic vulnerabilities. Liquid biopsies may compensate for inadequate genotyping, but remain less sensitive and specific compared with tissue biopsies. The liquid biopsy toolbox is poised to expand through novel assays and insights from longitudinal profiling. See related article by Sugimoto et al., p. 1506.
Medical subject headings
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms